Investore Property Limited logo

Capital Change Notice - Convertible Notes (IPLHA)

Capital Change25 September 2025IPLReal Estate

Capital Change Notice


Section 1: Issuer information

Name of issuer Investore Property Limited (Investore)

NZX ticker code IPLHA

Class of financial product Interest bearing subordinated convertible

notes (“Notes”)

ISIN (If unknown, check on NZX website) NZIPLDG001C8

Currency NZ$

Section 2: Capital change details

Number issued/acquired/redeemed 62,500,000

Nominal value (if any) NZ$62,500,000

Issue price per security $1.00

Nature of the payment (for example, cash or other

consideration)

Cash

Amount paid up (if not in full) Fully paid up

Percentage of total class of Financial Products

issued/acquired/redeemed/ (calculated on the

number of Financial Products of the Class,

excluding any Treasury Stock, in existence)

100%

For an issue of Convertible Financial Products or

Options, the principal terms of Conversion (for

example the Conversion price and Conversion date

and the ranking of the Financial Product in relation

to other Classes of Financial Product) or the Option

(for example, the exercise price and exercise date)

As set out in the product disclosure

statement dated 8 September 2025.

Subject to the cash election described

below, all outstanding Notes will be

converted into ordinary shares of

Investore on 26 September 2029.

Under the cash election, rather than

converting the Notes into ordinary shares

of Investore, Investore may (either in

whole or part) elect to instead pay a cash

amount to noteholders at the end of the

term as determined under the terms of the

Notes. Investore will announce whether it

intends to make a cash election for any

Notes on or before the conversion

announcement date (expected to be 19

September 2029).

The number of shares to be issued

following conversion of the Notes will be

determined by dividing the principal

amount (together with any accrued and



unpaid interest (and any interest thereon)

and less any taxes, withholdings or

deductions) by the conversion price, which

the lesser of:

1. the conversion price cap of $1.56;

and

2. a 2% discount to the Market Price.

The Market Price is determined based on

the arithmetic average of the daily volume

weighted average price of Investore’s

shares on the NZX Main Board in the 20

business days prior to (but not including)

the conversion announcement date.

The conversion price cap may be adjusted

in certain circumstances.

Reason for issue/acquisition/redemption and

specific authority for issue/acquisition/redemption/

(the reason for change must be identified here)

Reason for issue:

The net proceeds of the offer will be used

to repay existing bank debt, providing

Investore with the flexibility and additional

debt capacity to fund future acquisitions

including the purchase of the Silverdale

Centre from Stride Property Limited

(subject to shareholder approval), and for

general corporate purposes.

Specific authority for issue:

Resolutions of the Board of Directors of

Investore passed on 5 September 2025.

Total number of Financial Products of the Class

after the issue (excluding Treasury Stock) and the

total number of Financial Products of the Class

held as Treasury Stock after the issue.

62,500,000

Nil Treasury Stock

In the case of an acquisition of shares, whether

those shares are to be held as treasury stock

N/A

Specific authority for the issue, acquisition, or

redemption, including a reference to the rule

pursuant to which the issue, acquisition, or

redemption is made

Resolutions of the Board of Directors of

Investore passed on 5 September 2025.

Rule 4.5.1 for the issuance of the Notes

(read as if that rule applied to the Notes).

Rule 4.9.1(b)(i) for the issuance of shares

on conversion of the Notes.

Terms or details of the issue, acquisition, or

redemption (for example: restrictions, escrow

arrangements)

As set out in:

• the Master trust deed dated 2

March 2018 (amended 10 March

2021) and supplemented by the


Capital Change Notice



series supplement dated 8

September 2025; and

• the product disclosure statement

dated 8 September 2025.

Date of issue/acquisition/redemption Issued on: 26/09/2025

Section 3: Authority for this announcement and contact person

Name of person


authorised to make this

announcement

Jennifer Whooley, Company Secretary

Contact person for this announcement Jennfier Whooley

Contact phone number +64 (0)21 536 406

Contact email address jennifer.whooley@strideproperty.co.nz

Date of release through MAP


26/09/2025

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • PHL — Promisia Healthcare Limited: Capital Change Notice
    2025-09-03

    Capital Change Notice Updated as at February 2025 Section 1: Issuer information Name of issuer Promisia Healthcare Limited NZX ticker code PHL Class of financial product Unquoted convertible notes (Note) ISIN (If unknown, check on NZX website) N/A Currency NZD Sect…”